Coeptis Therapeutics Inc. Stock Prediction and Forecast [COEP]

AI-generated source summary

Coeptis Therapeutics Inc. (COEP) exhibits negative signals, particularly in its price-to-earnings ratio (-7.99), suggesting potential financial difficulties. While short-term technical indicators like MACD and moving averages have issued buy signals, these are countered by longer-term sell signals. The stock has experienced medium daily movements and poses a medium risk. A key resistance level is identified at $15.64, while support lies at $14.50. A break above resistance could signal a turnaround, but current data suggests a bearish outlook. Investors are advised to hold or accumulate cautiously, awaiting further developments and potential price increases above resistance levels.

AI-generated summary based on the source content.

Evidence and evaluation progress

1. Original source published

   03 Jan 2026, 04:56 UTC

   The analyst published the original source item.

2. First prediction resolved

   07 Jan 2026, 15:30 UTC

   The first evaluable outcome in this case reached a terminal result.

3. Case evaluation completed

   07 Jan 2026, 15:30 UTC

   All evaluable predictions in this case reached terminal outcomes.

4. Source recorded by Tahlil Plus

   18 May 2026, 20:23 UTC

   The public source was preserved as the evidence record for this case.

5. Market predictions extracted

   18 May 2026, 20:48 UTC

   1 eligible signal linked to this case.